Quick Answer
Yubo International Biotech Ltd reported Net Income of -$1.08 million for fiscal year 2025.
Yubo International Biotech Ltd Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$1.08M | +39.2% |
| 2024 | -$1.78M | -48.6% |
| 2023 | -$1.20M | +0.8% |
| 2022 | -$1.20M | +21.9% |
| 2021 | -$1.54M | -116.7% |
| 2020 | -$711.8K | -431.2% |
| 2020 | -$134.0K | +9.5% |
| 2019 | -$148.0K | -2.8% |
| 2018 | -$144.0K | +35.7% |
| 2017 | -$224.0K | -72.3% |
| 2016 | -$130.0K | -12.1% |
| 2015 | -$116.0K | -9.4% |
| 2014 | -$106.0K | -2.9% |
| 2013 | -$103.0K | -22.6% |
| 2012 | -$84.0K | +23.6% |
| 2011 | -$110.0K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$310.2K | +50.1% | -34.7% |
| June 30, 2025 | -$230.3K | +56.3% | +47.1% |
| March 31, 2025 | -$435.6K | -15.5% | +29.9% |
| September 30, 2024 | -$621.1K | -9968.9% | -17.7% |
| June 30, 2024 | -$527.5K | -43.6% | -39.8% |
| March 31, 2024 | -$377.3K | -19.1% | -6095.5% |
| September 30, 2023 | $6.3K | +102.6% | +101.7% |
| June 30, 2023 | -$367.3K | +25.3% | -16.0% |
- Yubo International Biotech Ltd showed an increase of +39.2% in Net Income compared to the prior fiscal year.
- Over the 2011–2025 period, Yubo International Biotech Ltd’s net income has declined by 881.1% (from -$110.0 thousand to -$1.08 million).
- The most recent figure is from Yubo International Biotech Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: